FDA to review risks of antidepressants in adults

BMJ 2004; 329 doi: http://dx.doi.org/10.1136/bmj.329.7470.816-b (Published 7 October 2004)
Cite this as: BMJ 2004;329:816.3

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jeanne Lenzer
  1. New York

    The US Food and Drug Administration (FDA) announced last week that it will examine whether antidepressants pose a similar risk of increased suicidal thoughts among adults as they do for children, by reanalysing data for adults.

    “Our first priority with regard to the adult data is to finish our analysis of the adult completed …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL